new drug

[sarah]

sounds good:

http://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_paloma_3_trial_for_ibrance_palboc iclib_stopped_early_due_to_efficacy_seen_in_patien ts_with_hr_her2_metastatic_breast_cancer_whose_dis ease_has_progressed_following_endocrine_therapy

[Mtngrl]

Good for ER+/PR+/HER-2- cancers. Most of us don't fit that profile. (I don't know why they used "HR" to indicate hormone-receptor positive. I haven't seen that before.